Affiliation:
1. Zambart
2. University Teaching Hospital
3. Biomedical Research Training Institute
4. St Mary's Hospital
5. Wolfson Institute of Population Health, Queen Mary University of London
6. London School of Hygiene & Tropical Medicine
Abstract
Abstract
Background: Tuberculosis (TB) continues to be a major cause of death across sub-Saharan Africa (SSA). In parallel, non-communicable disease and especially cardiovascular disease (CVD) burden has increased substantially in the region. Cardiac manifestations of TB are well-recognised but the extent to which they co-exist with pulmonary TB (PTB) has not been systematically evaluated. The aim of this study is to improve understanding of the burden of cardiac pathology in PTB in those living with and without HIV in a high-burden setting.
Methods: This is a cross-sectional and natural history study to evaluate the burden and natural history of cardiac pathology in participants with PTB in Lusaka, Zambia, a high burden setting for TB and HIV. Participants with PTB, with and without HIV will be consecutively recruited alongside age- and sex-matched TB-uninfected comparators on a 2:1 basis. Participants will undergo baseline assessments to collect clinical, socio-demographic, functional, laboratory and TB disease impact data followed by point-of-care and standard echocardiography. Participants with PTB will undergo further repeat clinical and functional examination at two- and six months follow-up. Those with cardiac pathology at baseline will undergo repeat echocardiography at six months.
Discussion: The outcomes of the study are to a) determine the burden of cardiac pathology at TB diagnosis, b) describe its association with patient-defining risk factors and biochemical markers of cardiac injury and stretch and c) describe the natural history of cardiac pathology during the course of TB treatment.
Publisher
Research Square Platform LLC
Reference35 articles.
1. National tuberculosis prevalence surveys in Africa, 2008–2016: an overview of results and lessons learned;Law I;Trop Med Int Health,2020
2. Organization WH. Global Tuberculosis Report 2021. Geneva: WHO; 2021.
3. Organization WH. WHO global lists of high burden countries for tuberculosis (TB), TB/HIV and multidrug/rifampicin-resistant TB (MDR/RR-TB), 2021–2025: background document. Geneva: World Health Organization; 2021.
4. Cardiovascular morbidity and mortality among persons diagnosed with tuberculosis: A systematic review and meta-analysis;Basham CA;PLoS ONE,2020
5. Neglected Tropical Diseases and Other Infectious Diseases Affecting the Heart. The NET-Heart Project: Rationale and Design;Burgos LM;Global Heart,2020